Dose of Reality - TILT most undervalued stock - see belowFor those new to the board, we have a few shorties still trying to get shares cheap before TILT makes the big run to its actual value. The only information you need to know is below.
1. TILT is #7 in revenue out of 55 companies
2. Fully dilluted market cap / revenue is 2.62, The lowest of all top 10 revenue producers by by far. The average
Fully dilluted market cap / revenue is 43.89. This would put tilt at a share price of $5.52. Most analysts have place TILT over $2.00 CAD conservatively 3. TILT Holdings Reports Third Quarter Revenue of US$46.1M, Positive Adjusted EBITDA of US$2.7M Third Quarter Revenue Increased 18% Over the Second Quarter of 2019
Positive Third Quarter Adjusted EBITDA of US$2.7M Marks Turning Point for Company
- Third Quarter 2019 and Recent Financial and Operational Highlights:
- Revenue of US$46.1M in the third quarter of 2019, an 18% increase from the second quarter of 2019.
- Posted first-ever positive adjusted EBITDA quarter, US$2.7M, up from negative US($4.0M) in the second quarter of 2019.
- Announced the closing of US$25.6M of a US$35.0M shareholder backed financing.
- Announced forfeiture of approximately 60 million stock options from its founders, resulting in a positive US$37M adjustment to net income.
- Jupiter Research experienced quarter-over-quarter international sales growth of 70%.
- Commonwealth Alternative Care experienced quarter-over-quarter sales growth of 218%.
- Refocused corporate strategy highlighting success of core operating assets, including refreshed TILT website.
- Reached milestone of supporting over 2,000 brands within the cannabis industry.
- Expanded retail offerings from Jupiter Research asset
CANNABIS QUARTERLY REVENUE Cannabis Revenue Tracker